These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25465803)

  • 1. Prediction of long-term outcome after acute myocardial infarction using circulating miR-145.
    Dong YM; Liu XX; Wei GQ; Da YN; Cha L; Ma CS
    Scand J Clin Lab Invest; 2015 Jan; 75(1):85-91. PubMed ID: 25465803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of serum tenascin-C levels on long-term outcome after acute myocardial infarction.
    Sato A; Hiroe M; Akiyama D; Hikita H; Nozato T; Hoshi T; Kimura T; Wang Z; Sakai S; Imanaka-Yoshida K; Yoshida T; Aonuma K
    J Card Fail; 2012 Jun; 18(6):480-6. PubMed ID: 22633306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction.
    van de Hoef TP; Bax M; Meuwissen M; Damman P; Delewi R; de Winter RJ; Koch KT; Schotborgh C; Henriques JP; Tijssen JG; Piek JJ
    Circ Cardiovasc Interv; 2013 Jun; 6(3):207-15. PubMed ID: 23735476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MicroRNA-146a and MicroRNA-21 Predict Left Ventricular Remodeling after ST-Elevation Myocardial Infarction.
    Liu X; Dong Y; Chen S; Zhang G; Zhang M; Gong Y; Li X
    Cardiology; 2015; 132(4):233-41. PubMed ID: 26337652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study.
    Shiomi H; Nakagawa Y; Morimoto T; Furukawa Y; Nakano A; Shirai S; Taniguchi R; Yamaji K; Nagao K; Suyama T; Mitsuoka H; Araki M; Takashima H; Mizoguchi T; Eisawa H; Sugiyama S; Kimura T;
    BMJ; 2012 May; 344():e3257. PubMed ID: 22623632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of troponin T release kinetics to long-term clinical outcome in patients with acute ST segment elevation myocardial infarction treated with a percutaneous intervention.
    Karavidas AJ; Vrachatis AD; Alpert MA; Nikas DJ; Achtypis DI; Masrakas EP; Foukarakis MG; Fotiades TN; Zacharoulis AA
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):312-9. PubMed ID: 12112882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis after primary PCI in unselected patients with ST-elevation myocardial infarction.
    Barchielli A; Santoro GM; Balzi D; Carrabba N; Di Bari M; Gensini GF; Filice M; Landini CM; Valente S; Zuppiroli A; Marchionni N
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):819-27. PubMed ID: 22772599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction.
    Hashimoto T; Ishii J; Kitagawa F; Yamada S; Hattori K; Okumura M; Naruse H; Motoyama S; Matsui S; Tanaka I; Izawa H; Maruyama I; Nomura M; Ozaki Y
    Atherosclerosis; 2012 Apr; 221(2):490-5. PubMed ID: 22369934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction.
    Amabile N; Jacquier A; Shuhab A; Gaudart J; Bartoli JM; Paganelli F; Moulin G
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1101-8. PubMed ID: 21805604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
    de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
    N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.